Business Segments · CapEx
Life Sciences and Emerging Growth Businesses — CapEx
Corning Life Sciences and Emerging Growth Businesses — CapEx decreased by 37.5% to $5.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026
How to read this metric
Higher spending signals growth initiatives or capacity expansion, while lower spending may indicate a focus on cash preservation or mature operations.
Detailed definition
This metric tracks the cash spent by the Life Sciences and Emerging Growth segment to acquire, upgrade, or maintain phys...
Peer comparison
Comparable to capital expenditure (CapEx) metrics for manufacturing and R&D-focused business units.
Metric ID:
glw_segment_life_sciences_and_emerging_growth_businesses_capital_expendituresHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $8.00M | $5.00M |
| QoQ Change | — | -37.5% |
| YoY Change | — | -37.5% |
Range$5.00M – $8.00M
Avg YoY Growth-37.5%
Median YoY Growth-37.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Corning's life sciences and emerging growth businesses — capex?
- Corning (GLW) reported life sciences and emerging growth businesses — capex of $5.00M in Q1 2026.
- What does life sciences and emerging growth businesses — capex mean?
- The amount invested in physical assets for the Life Sciences and Emerging Growth segment.